TL;DR
Get your wardrobe favorites delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Esquire published a curated roundup of six wearable devices aimed at specific tasks, including blood pressure monitoring, stress alerts, audio transcription and vagus nerve stimulation. The report describes product features and the editor’s experiences, but it does not establish that every device’s health claims are clinically proven; it specifically notes regulatory and hands-on-testing limits for some products.
Esquire has published a curated list of six wearable devices designed for tasks including blood pressure tracking, stress prompts, audio transcription and nerve stimulation. The roundup describes how the products are intended to work, while also flagging limits in regulatory clearance and firsthand testing that matter to readers weighing health-related claims.
The devices covered are the Hilo Core system and Signal Ring for blood pressure, Plaud’s NotePin S audio recorder, Pulsetto and Sona vagus nerve stimulators, and the Pulse smart ring for stress alerts. The list focuses on products with a defined use rather than general activity or sleep tracking.
According to the report, Hilo combines a band and app with an FDA-cleared blood pressure cuff. Users first take baseline readings with the cuff for several days, then are expected to use it about monthly for calibration; the band is intended to track readings between calibrations. Esquire says the Hilo Band itself is not FDA-cleared. Signal is described as a cuff-free ring that measures systolic and diastolic blood pressure. Its maker commissioned a 451-person study that the report says met the ISO 81060-2 accuracy standard, but the ring is not FDA-cleared.
Plaud’s NotePin S is a small recorder worn clipped to clothing, as a necklace or in a wristband. The company’s device can record audio and generate transcripts, according to the roundup. Pulsetto and Sona are both presented as vagus nerve stimulation devices, while Pulse uses physiological signals to prompt users with vibrations when it detects possible stress. These descriptions concern product functions and intended benefits; they do not, on their own, establish clinical effectiveness.
Practical Uses, With Health Caveats
The roundup points to a shift in wearable technology from broad wellness dashboards toward specific, everyday jobs: tracking a health measure, capturing a conversation or prompting a pause during a stressful day. For people who find repeated cuff readings inconvenient, the Hilo and Signal concepts aim to make blood pressure monitoring easier to integrate into daily routines. The trade-off is that ease of use does not answer whether a device is sufficiently accurate or appropriate for clinical decisions.
The distinction is particularly relevant for medical monitoring. The report identifies regulatory limits for both blood pressure products: the Hilo cuff is FDA-cleared, but the Hilo Band and Signal Ring are not. A commissioned study cited for Signal is a piece of evidence, not a substitute for the regulatory status stated in the article. Readers should not treat product descriptions as medical advice or change prescribed monitoring based on a wearable without consulting a health professional.
For the other products, the value is more personal and task-based. A recorder may reduce manual note-taking, while stress alerts or stimulation devices may fit into some users’ routines. The Esquire writer reports a positive personal experience with Pulsetto for relaxation but says results may vary; the writer had not tried Sona and did not offer a full endorsement. Those qualifications put the claims in perspective.
Popular right now
Shark AI Ultra Robot Vacuum with Matrix Clean Navigation, Self-Empty Base, HEPA Filtration, Pet Hair Friendly, Wi‑Fi, Dark Grey
KitchenAid Artisan Mini 3.5-Qt Tilt-Head Stand Mixer, Candy Apple Red
Roborock RockMow X130H Wire-Free 4WD Robot Lawn Mower
As an affiliate, we earn on qualifying purchases.
Six Devices, Different Purposes
The Esquire piece is a product roundup, not a clinical trial or regulatory review. It says products were selected by an editor and discloses that Esquire may earn commission from links. That commercial disclosure is relevant when interpreting a shopping-focused article, although it does not establish that a product’s claims are false.
The six items fall into three broad groups. Hilo and Signal are intended to track blood pressure; NotePin S records and transcribes audio; and Pulsetto, Pulse and Sona address stress or stimulation through different approaches. The report distinguishes the ring’s claimed direct blood pressure readings from broader cardiovascular indicators, but the supplied material does not provide independent comparative testing across devices.
Product descriptions also differ in how much firsthand evaluation they received. The writer describes using Pulsetto and says the NotePin S can be worn in several ways, but explicitly says they had not tried Sona. Wearable features and health outcomes should not be treated as equally verified simply because the devices appear together in one list.
“The device itself is not yet FDA cleared.”
— Esquire report
Evidence and Clearance Gaps
The supplied report does not provide publication-date details, independent head-to-head accuracy data, or full study methods for Signal’s 451-person company-commissioned study. It says the study met an international accuracy standard, but does not establish in the supplied text how the ring performs across different users or in routine settings. The regulatory status of the Signal Ring and Hilo Band is stated as not FDA-cleared.
It is also unclear from the material how well the stress-detection and nerve-stimulation products perform in controlled research, what outcomes users can reasonably expect, or how long benefits may last. The writer says Sona was not tested firsthand and reports that Pulsetto results may vary. No independent evidence or detailed clinical outcomes are supplied for the other devices.
What Buyers Should Verify
The report does not announce a product launch, regulatory decision or upcoming trial. For readers considering a device, the next step is to check the current regulatory status, evidence, limitations and intended use directly with the manufacturer and relevant health professionals. People monitoring blood pressure should follow their clinician’s measurement plan rather than rely on an uncleared wearable as a replacement.
For recording and stress products, buyers can compare how the device handles audio and personal data, what subscriptions or accessories cost, and whether its functions fit their needs. The roundup supplies no independent performance update or scheduled follow-up, so changes in clearance, research and availability remain to be confirmed.
Key Questions
Which devices in the roundup are for blood pressure monitoring?
Hilo Core and the Signal Ring are presented as blood pressure products. Hilo uses a band, app and cuff for baseline readings and periodic calibration; Signal is described as a cuff-free ring.
Are the Hilo Band and Signal Ring FDA-cleared?
The report says neither the Hilo Band nor Signal Ring is FDA-cleared. It says the cuff included in the Hilo system is FDA-cleared.
What does the Plaud NotePin S do?
The NotePin S is a wearable audio recorder that can transcribe recorded audio, according to the Esquire roundup. It can be clipped to clothing or worn with included attachments.
Does the report prove that the stress or nerve-stimulation devices work?
No. The article describes intended functions and a writer’s personal experience with Pulsetto, but it does not provide enough independent clinical evidence to establish effectiveness for all users. The writer says results may vary and had not tested Sona firsthand.
Source: esquire.com
